{"parse":{"title":"CVac","pageid":35431425,"revid":856955648,"text":{"*":"<div class=\"mw-parser-output\"><table class=\"plainlinks metadata ambox ambox-content ambox-multiple_issues compact-ambox\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Ambox_important.svg/40px-Ambox_important.svg.png\" width=\"40\" height=\"40\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Ambox_important.svg/60px-Ambox_important.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Ambox_important.svg/80px-Ambox_important.svg.png 2x\" data-file-width=\"40\" data-file-height=\"40\" /></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\"><div class=\"mw-collapsible\" style=\"width:95%; margin: 0.2em 0;\"><b>This article has multiple issues.</b> Please help <b><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=CVac&amp;action=edit\">improve it</a></b> or discuss these issues on the <b><a href=\"/wiki/Talk:CVac\" title=\"Talk:CVac\">talk page</a></b>. <small><i>(<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove these template messages</a>)</i></small>\n<div class=\"mw-collapsible-content\" style=\"margin-top: 0.3em;\">\n      <table class=\"plainlinks metadata ambox ambox-content\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Ambox_important.svg/40px-Ambox_important.svg.png\" width=\"40\" height=\"40\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Ambox_important.svg/60px-Ambox_important.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Ambox_important.svg/80px-Ambox_important.svg.png 2x\" data-file-width=\"40\" data-file-height=\"40\" /></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This article <b>reads like <a href=\"/wiki/Wikipedia:What_Wikipedia_is_not#SOAPBOX\" title=\"Wikipedia:What Wikipedia is not\">a press release</a> or <a href=\"/wiki/Wikipedia:What_Wikipedia_is_not#NEWS\" title=\"Wikipedia:What Wikipedia is not\">a news article</a></b> or <b>is largely based on <a href=\"/wiki/Wikipedia:Notability_(events)#Routine_coverage\" title=\"Wikipedia:Notability (events)\">routine coverage</a></b> or <b><a href=\"/wiki/Wikipedia:Notability_(events)#Sensationalism\" title=\"Wikipedia:Notability (events)\">sensationalism</a></b>.<span class=\"hide-when-compact\"> Please <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=CVac&amp;action=edit\">expand this article</a> with <a href=\"/wiki/Wikipedia:Identifying_reliable_sources\" title=\"Wikipedia:Identifying reliable sources\">properly sourced content</a> to meet Wikipedia's <a href=\"/wiki/Wikipedia:Manual_of_Style\" title=\"Wikipedia:Manual of Style\">\nquality standards</a>, <a href=\"/wiki/Wikipedia:Notability_(events)\" title=\"Wikipedia:Notability (events)\">event notability guideline</a>, or <a href=\"/wiki/Wikipedia:What_Wikipedia_is_not\" title=\"Wikipedia:What Wikipedia is not\">encyclopedic content policy</a>.</span>  <small><i>(December 2015)</i></small></div></td></tr></tbody></table>\n<table class=\"plainlinks metadata ambox ambox-content\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><a href=\"/wiki/File:Question_book-new.svg\" class=\"image\"><img alt=\"Question book-new.svg\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png\" width=\"50\" height=\"39\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x\" data-file-width=\"512\" data-file-height=\"399\" /></a></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This article <b>may rely excessively on sources <a href=\"/wiki/Wikipedia:BLOGS\" class=\"mw-redirect\" title=\"Wikipedia:BLOGS\">too closely associated with the subject</a></b>, potentially preventing the article from being <a href=\"/wiki/Wikipedia:Verifiability\" title=\"Wikipedia:Verifiability\">verifiable</a> and <a href=\"/wiki/Wikipedia:Neutral_point_of_view\" title=\"Wikipedia:Neutral point of view\">neutral</a>.<span class=\"hide-when-compact\"> Please help <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=CVac&amp;action=edit\">improve it</a> by replacing them with more appropriate <a href=\"/wiki/Wikipedia:Citing_sources\" title=\"Wikipedia:Citing sources\">citations</a> to <a href=\"/wiki/Wikipedia:Identifying_and_using_independent_sources\" title=\"Wikipedia:Identifying and using independent sources\">reliable, independent, third-party sources</a>.</span>  <small><i>(December 2015)</i></small><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n    </div>\n</div><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n<p><b>CVac</b>, short for \u2018Cancer Vaccine\u2019, is a potential <a href=\"/wiki/Immunotherapy\" title=\"Immunotherapy\">immunotherapeutic</a> agent that  developed in <a href=\"/wiki/Australia\" title=\"Australia\">Australia</a>.\n</p><p>CVac was developed by the <a href=\"/wiki/Biotechnology\" title=\"Biotechnology\">biotechnology</a> company <a href=\"/wiki/Prima_BioMed\" class=\"mw-redirect\" title=\"Prima BioMed\">Prima BioMed</a> (<a href=\"/wiki/Nasdaq\" class=\"mw-redirect\" title=\"Nasdaq\">Nasdaq</a>: PBMD) through to Phase II clinical studies between 2001 and 2015. After inconclusive clinical data in <a href=\"/wiki/Ovarian_cancer\" title=\"Ovarian cancer\">ovarian cancer</a> 2013 and 2014, Prima announced in February 2015 that it had ceased recruiting into CVAc clinical studies and was seeking commercial partners for the product.<sup id=\"cite_ref-1\" class=\"reference\"><a href=\"#cite_note-1\">&#91;1&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Treatment_method\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Treatment method</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Early_development_in_Melbourne\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Early development in Melbourne</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Development_by_Prima_BioMed\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Development by Prima BioMed</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#Dubai_Approval\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Dubai Approval</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#Manufacturing\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Manufacturing</span></a></li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#References\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-7\"><a href=\"#Further_reading\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">Further reading</span></a></li>\n<li class=\"toclevel-1 tocsection-8\"><a href=\"#External_links\"><span class=\"tocnumber\">8</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Treatment_method\">Treatment method</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=CVac&amp;action=edit&amp;section=1\" title=\"Edit section: Treatment method\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>CVac is an <i><a href=\"/wiki/Ex_vivo\" title=\"Ex vivo\">ex vivo</a></i> dendritic cell priming technology involving MFP, or mannan <a href=\"/wiki/Fusion_protein\" title=\"Fusion protein\">fusion protein</a>, where a fusion protein of MUC1 and <a href=\"/wiki/Glutathione_S-transferase\" title=\"Glutathione S-transferase\">Glutathione S-transferase</a> is coupled to oxidized polymannose. The dendritic cells are the orchestrators of the immune system. \u2018Priming\u2019 dendritic cells involves exposing those cells to disease antigens in order to get the immune system to properly recognise the antigen and mount an appropriate response.  With CVac this takes place outside the body of the patient (<i>ex vivo</i>), with dendritic cells obtained by <a href=\"/wiki/Leukapheresis\" title=\"Leukapheresis\">leukapheresis</a>. The antigen in this case is MUC1,   known to be overexpressed on a variety of cancer cells<sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup> and in CVac MUC1 is conjugated to the carbohydrate mannan to facilitate uptake by the dendritic cells. CVAc can be administered subcutaneously, whereas Provenge is intravenous.<sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Early_development_in_Melbourne\">Early development in Melbourne</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=CVac&amp;action=edit&amp;section=2\" title=\"Edit section: Early development in Melbourne\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>CVac originated in the mid-1990s at the Austin Research Institute, a medical research facility then associated with Melbourne's <a href=\"/wiki/Austin_Hospital,_Melbourne\" title=\"Austin Hospital, Melbourne\">Austin Hospital</a> (and that merged with the <a href=\"/wiki/Burnet_Institute\" title=\"Burnet Institute\">Burnet Institute</a> in 2006). The original version of the product was developed in the laboratory of the Austin  Professor Ian McKenzie in 1993.<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup> CVac therapy was originally intended to be <i>in vivo</i> but the Austin researchers started getting better results in <i>ex vivo</i> therapy.\n</p>\n<h2><span class=\"mw-headline\" id=\"Development_by_Prima_BioMed\">Development by Prima BioMed</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=CVac&amp;action=edit&amp;section=3\" title=\"Edit section: Development by Prima BioMed\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Prima BioMed was formed around 2001 to commercialise a number of Austin Research Institute projects including CVac. The company was taken public in July 2001 on the ASX in a <a href=\"/wiki/Reverse_takeover\" title=\"Reverse takeover\">reverse takeover</a> of a defunct mineral explorer called Prima Resources.<sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup> CVac ultimately ended up as Prima BioMed's core project until Prima's acquisition of the French biotechnology company Immutep SA in 2014.\n</p>\n<h2><span class=\"mw-headline\" id=\"Dubai_Approval\">Dubai Approval</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=CVac&amp;action=edit&amp;section=4\" title=\"Edit section: Dubai Approval\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>CVac was approved for use by the <a href=\"/wiki/Dubai_Health_Authority\" title=\"Dubai Health Authority\">Dubai Health City Authority</a> in May 2011.<sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Manufacturing\">Manufacturing</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=CVac&amp;action=edit&amp;section=5\" title=\"Edit section: Manufacturing\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>CVac was manufactured in <a href=\"/wiki/Germany\" title=\"Germany\">Germany</a> by Fraunhofer IZI (Das Fraunhofer-Institut f\u00fcr Zelltherapie und Immunologie), an institute of the <a href=\"/wiki/Fraunhofer_Society\" title=\"Fraunhofer Society\">Fraunhofer Society</a> in <a href=\"/wiki/Leipzig\" title=\"Leipzig\">Leipzig</a>, <a href=\"/wiki/Saxony\" title=\"Saxony\">Saxony</a><sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup> The Fraunhofer IZI was authorized to manufacture the treatment in Europe in late 2011 after meeting criteria laid down by the German <i>Arzneimittelgesetz</i> (Drug Law). Prima intended that its product would be manufactured at this one central location, with patient blood being flown to Leipzig and primed dendritic cells being shipped back to the relevant trial site.\n</p>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=CVac&amp;action=edit&amp;section=6\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist columns references-column-width\" style=\"-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;\">\n<ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-1\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.primabiomed.com.au/investor/pdf/2015/27_02_2015_announcement.pdf\">\"Prima BioMed Prioritising IMP321\"</a> <span style=\"font-size:85%;\">(PDF)</span>. Prima BioMed market release. 27 February 2015<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 June</span> 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Prima+BioMed+Prioritising+IMP321&amp;rft.date=2015-02-27&amp;rft_id=http%3A%2F%2Fwww.primabiomed.com.au%2Finvestor%2Fpdf%2F2015%2F27_02_2015_announcement.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACVac\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Rakha EA, Boyce RW, Abd El-Rehim D, Kurien T, Green AR, Paish EC, Robertson JF, Ellis IO (October 1, 2005). \"Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer\". <i>Mod. Pathol</i>. <b>18</b> (10): 1295\u20131304. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/modpathol.3800445\">10.1038/modpathol.3800445</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15976813\">15976813</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mod.+Pathol.&amp;rft.atitle=Expression+of+mucins+%28MUC1%2C+MUC2%2C+MUC3%2C+MUC4%2C+MUC5AC+and+MUC6%29+and+their+prognostic+significance+in+human+breast+cancer.&amp;rft.volume=18&amp;rft.issue=10&amp;rft.pages=1295-1304&amp;rft.date=2005-10-01&amp;rft_id=info%3Adoi%2F10.1038%2Fmodpathol.3800445&amp;rft_id=info%3Apmid%2F15976813&amp;rft.aulast=Rakha&amp;rft.aufirst=EA&amp;rft.au=Boyce%2C+RW&amp;rft.au=Abd+El-Rehim%2C+D&amp;rft.au=Kurien%2C+T&amp;rft.au=Green%2C+AR&amp;rft.au=Paish%2C+EC&amp;rft.au=Robertson%2C+JF&amp;rft.au=Ellis%2C+IO&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACVac\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Schr\u00f6der, L. (May 1, 2013). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.primabiomed.com.au/investor/pdf/2013/2013_05_AEBSInnenteil_eng.pdf\">\"Autologous immunotherapy for ovarian carcinoma \u2013 A new chance?\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>\u00c4rzteblatt Sachsen</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 June</span> 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=%C3%84rzteblatt+Sachsen&amp;rft.atitle=Autologous+immunotherapy+for+ovarian+carcinoma+%E2%80%93+A+new+chance%3F&amp;rft.date=2013-05-01&amp;rft.aulast=Schr%C3%B6der&amp;rft.aufirst=L.&amp;rft_id=http%3A%2F%2Fwww.primabiomed.com.au%2Finvestor%2Fpdf%2F2013%2F2013_05_AEBSInnenteil_eng.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACVac\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><span class=\"citation patent\" id=\"CITEREFVasso_Apostolopoulos2018\"><a rel=\"nofollow\" class=\"external text\" href=\"https://worldwide.espacenet.com/textdoc?DB=EPODOC&amp;IDX=WO1995018145\">WO&#32;application 1995018145</a>,&#32;Vasso Apostolopoulos,&#32;\"Conjugates of human mucin and a carbohydrate polymer and their use in cancer treatment\",&#32;published 1995-07-06,&#32; assigned to Austin Research Institute</span><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&amp;rft.applnumber=1995018145&amp;rft.cc=WO&amp;rft.title=Conjugates+of+human+mucin+and+a+carbohydrate+polymer+and+their+use+in+cancer+treatment&amp;rft.inventor=Vasso+Apostolopoulos&amp;rft.assignee=Austin+Research+Institute&amp;rft.appldate=1994-12-23&amp;rft.pubdate=1995-07-06&amp;rft.prioritydate=1993-12-24\"><span style=\"display: none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.asxonline.com/intradoc-cgi/groups/participant_services/documents/communications/asx004875.pdf\">\"Prima BioMed Ltd (formerly Prima Resources Ltd) - Reinstatement of securities to Official Quotation\"</a> <span style=\"font-size:85%;\">(PDF)</span>. Australian Stock Exchange Participant Circular. 6 July 2001<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 June</span> 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Prima+BioMed+Ltd+%28formerly+Prima+Resources+Ltd%29+-+Reinstatement+of+securities+to+Official+Quotation&amp;rft.date=2001-07-06&amp;rft_id=https%3A%2F%2Fwww.asxonline.com%2Fintradoc-cgi%2Fgroups%2Fparticipant_services%2Fdocuments%2Fcommunications%2Fasx004875.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACVac\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Ferris-Lay, Claire (2 June 2011). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.arabianbusiness.com/new-ovarian-cancer-treatment-approved-in-dubai-403287.html\">\"New ovarian cancer treatment approved in Dubai\"</a>. arabianbusiness.com<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 June</span> 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=New+ovarian+cancer+treatment+approved+in+Dubai&amp;rft.date=2011-06-02&amp;rft.aulast=Ferris-Lay&amp;rft.aufirst=Claire&amp;rft_id=http%3A%2F%2Fwww.arabianbusiness.com%2Fnew-ovarian-cancer-treatment-approved-in-dubai-403287.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACVac\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20160304101551/http://www.izi.fraunhofer.de/presseinformationen-lang.html?&amp;L=1&amp;tx_ttnews%5Btt_news%5D=97&amp;cHash=89d4773718ceaf5bcb60e558eab54930\">\"Fraunhofer IZI received manufacturing authorization for tumor vaccine CVac\"</a>. Fraunhofer IZI press release. 28 October 2011. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.izi.fraunhofer.de/presseinformationen-lang.html?&amp;L=1&amp;tx_ttnews%5Btt_news%5D=97&amp;cHash=89d4773718ceaf5bcb60e558eab54930\">the original</a> on 4 March 2016<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 June</span> 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Fraunhofer+IZI+received+manufacturing+authorization+for+tumor+vaccine+CVac&amp;rft.date=2011-10-28&amp;rft_id=http%3A%2F%2Fwww.izi.fraunhofer.de%2Fpresseinformationen-lang.html%3F%26L%3D1%26tx_ttnews%255Btt_news%255D%3D97%26cHash%3D89d4773718ceaf5bcb60e558eab54930&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACVac\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div>\n<h2><span class=\"mw-headline\" id=\"Further_reading\">Further reading</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=CVac&amp;action=edit&amp;section=7\" title=\"Edit section: Further reading\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li>Madan, Aragon-Ching, Gulley, Dahut. From Clinical Trials to Clinical Practice. Expert Review of Vaccines. 2011. <a rel=\"nofollow\" class=\"external free\" href=\"http://www.medscape.com/viewarticle/747473\">http://www.medscape.com/viewarticle/747473</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=CVac&amp;action=edit&amp;section=8\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external free\" href=\"http://primabiomed.com.au/\">http://primabiomed.com.au/</a></li></ul>\n\n<!-- \nNewPP limit report\nParsed by mw1300\nCached time: 20180909020959\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.172 seconds\nReal time usage: 0.225 seconds\nPreprocessor visited node count: 885/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 38075/2097152 bytes\nTemplate argument size: 8248/2097152 bytes\nHighest expansion depth: 16/40\nExpensive parser function count: 2/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 8570/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.067/10.000 seconds\nLua memory usage: 2.73 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  179.039      1 -total\n 57.35%  102.681      3 Template:Ambox\n 49.24%   88.156      1 Template:Multiple_issues\n 47.27%   84.632      1 Template:Reflist\n 24.31%   43.518      4 Template:Cite_news\n 14.53%   26.012      1 Template:Cleanup-PR\n 12.65%   22.647      1 Template:Third-party\n  8.13%   14.552      1 Template:DMCA\n  7.69%   13.765      2 Template:Cite_journal\n  6.97%   12.473      1 Template:Dated_maintenance_category\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:35431425-0!canonical and timestamp 20180909021000 and revision id 856955648\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"","hidden":"","*":"Articles_with_a_promotional_tone_from_December_2015"},{"sortkey":"","hidden":"","*":"All_articles_with_a_promotional_tone"},{"sortkey":"","hidden":"","*":"Articles_lacking_reliable_references_from_December_2015"},{"sortkey":"","hidden":"","*":"All_articles_lacking_reliable_references"},{"sortkey":"","hidden":"","*":"Articles_with_multiple_maintenance_issues"},{"sortkey":"","*":"Vaccination"},{"sortkey":"","*":"Cancer"}],"links":[{"ns":14,"exists":"","*":"Category:Articles with a promotional tone from December 2015"},{"ns":14,"exists":"","*":"Category:Articles lacking reliable references from December 2015"},{"ns":0,"exists":"","*":"Austin Hospital, Melbourne"},{"ns":0,"exists":"","*":"Australia"},{"ns":0,"exists":"","*":"Biotechnology"},{"ns":0,"exists":"","*":"Burnet Institute"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Dubai Health Authority"},{"ns":0,"exists":"","*":"Ex vivo"},{"ns":0,"exists":"","*":"Fraunhofer Society"},{"ns":0,"exists":"","*":"Fusion protein"},{"ns":0,"exists":"","*":"Germany"},{"ns":0,"exists":"","*":"Glutathione S-transferase"},{"ns":0,"exists":"","*":"Immunotherapy"},{"ns":0,"exists":"","*":"Leipzig"},{"ns":0,"exists":"","*":"Leukapheresis"},{"ns":0,"exists":"","*":"Nasdaq"},{"ns":0,"exists":"","*":"Ovarian cancer"},{"ns":0,"exists":"","*":"Prima BioMed"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Reverse takeover"},{"ns":0,"exists":"","*":"Saxony"},{"ns":1,"exists":"","*":"Talk:CVac"},{"ns":4,"exists":"","*":"Wikipedia:BLOGS"},{"ns":4,"exists":"","*":"Wikipedia:Citing sources"},{"ns":4,"exists":"","*":"Wikipedia:Identifying and using independent sources"},{"ns":4,"exists":"","*":"Wikipedia:Identifying reliable sources"},{"ns":4,"exists":"","*":"Wikipedia:Manual of Style"},{"ns":4,"exists":"","*":"Wikipedia:Neutral point of view"},{"ns":4,"exists":"","*":"Wikipedia:Notability (events)"},{"ns":4,"exists":"","*":"Wikipedia:Verifiability"},{"ns":4,"exists":"","*":"Wikipedia:What Wikipedia is not"},{"ns":12,"exists":"","*":"Help:Maintenance template removal"}],"templates":[{"ns":10,"exists":"","*":"Template:Multiple issues"},{"ns":10,"exists":"","*":"Template:Ambox"},{"ns":10,"exists":"","*":"Template:Cleanup-PR"},{"ns":10,"exists":"","*":"Template:Third-party"},{"ns":10,"exists":"","*":"Template:DMCA"},{"ns":10,"exists":"","*":"Template:Dated maintenance category"},{"ns":10,"exists":"","*":"Template:FULLROOTPAGENAME"},{"ns":10,"exists":"","*":"Template:Ns has subpages"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Column-width"},{"ns":10,"exists":"","*":"Template:Cite news"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite patent"},{"ns":10,"exists":"","*":"Template:Citation/patent"},{"ns":10,"exists":"","*":"Template:Citation/make link"},{"ns":10,"exists":"","*":"Template:Citation/authors"},{"ns":828,"exists":"","*":"Module:Message box"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Message box/configuration"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Ns has subpages"},{"ns":828,"exists":"","*":"Module:String"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"}],"images":["Ambox_important.svg","Question_book-new.svg"],"externallinks":["http://www.primabiomed.com.au/investor/pdf/2015/27_02_2015_announcement.pdf","//doi.org/10.1038/modpathol.3800445","//www.ncbi.nlm.nih.gov/pubmed/15976813","http://www.primabiomed.com.au/investor/pdf/2013/2013_05_AEBSInnenteil_eng.pdf","https://worldwide.espacenet.com/textdoc?DB=EPODOC&IDX=WO1995018145","https://www.asxonline.com/intradoc-cgi/groups/participant_services/documents/communications/asx004875.pdf","http://www.arabianbusiness.com/new-ovarian-cancer-treatment-approved-in-dubai-403287.html","https://web.archive.org/web/20160304101551/http://www.izi.fraunhofer.de/presseinformationen-lang.html?&L=1&tx_ttnews%5Btt_news%5D=97&cHash=89d4773718ceaf5bcb60e558eab54930","http://www.izi.fraunhofer.de/presseinformationen-lang.html?&L=1&tx_ttnews%5Btt_news%5D=97&cHash=89d4773718ceaf5bcb60e558eab54930","http://www.medscape.com/viewarticle/747473","http://primabiomed.com.au/"],"sections":[{"toclevel":1,"level":"2","line":"Treatment method","number":"1","index":"1","fromtitle":"CVac","byteoffset":822,"anchor":"Treatment_method"},{"toclevel":1,"level":"2","line":"Early development in Melbourne","number":"2","index":"2","fromtitle":"CVac","byteoffset":2356,"anchor":"Early_development_in_Melbourne"},{"toclevel":1,"level":"2","line":"Development by Prima BioMed","number":"3","index":"3","fromtitle":"CVac","byteoffset":3188,"anchor":"Development_by_Prima_BioMed"},{"toclevel":1,"level":"2","line":"Dubai Approval","number":"4","index":"4","fromtitle":"CVac","byteoffset":3947,"anchor":"Dubai_Approval"},{"toclevel":1,"level":"2","line":"Manufacturing","number":"5","index":"5","fromtitle":"CVac","byteoffset":4342,"anchor":"Manufacturing"},{"toclevel":1,"level":"2","line":"References","number":"6","index":"6","fromtitle":"CVac","byteoffset":5470,"anchor":"References"},{"toclevel":1,"level":"2","line":"Further reading","number":"7","index":"7","fromtitle":"CVac","byteoffset":5502,"anchor":"Further_reading"},{"toclevel":1,"level":"2","line":"External links","number":"8","index":"8","fromtitle":"CVac","byteoffset":5682,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"CVac","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q22907609"}]}}